{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:58:18Z","timestamp":1791259098713,"version":"4.1.0"},"reference-count":57,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Thromb Hemost"],"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Tranexamic acid (TXA) is an antifibrinolytic drug primarily used for reducing blood loss in patients with major bleedings. Animal and cell studies have shown that TXA might modulate the inflammatory response by either enhancing or inhibiting cytokine levels. Furthermore, recent human studies have found altered inflammatory biomarkers in patients receiving TXA when compared with patients who did not receive TXA. In this systematic review we investigated the effect of TXA on inflammatory biomarkers in different patient groups. A systematic literature search was conducted on the databases PubMed and Embase to identify all original articles that investigated inflammatory biomarkers in patients receiving TXA and compared them to a relevant control group. The review was performed according to the PRISMA guidelines, and the literature search was performed on November 29, 2021. Thirty-three studies were included, among which 14 studies compared patients receiving TXA with patients getting no medication, another 14 studies investigated different dosing regimens of TXA, and finally five studies examined the administration form of TXA. The present review suggests that TXA has an anti-inflammatory effect in patients undergoing orthopaedic surgery illustrated by decreased levels of C-reactive protein and interleukin-6 in patients receiving TXA compared with patients receiving no or lower doses of TXA. However, the anti-inflammatory effect was not found in patients undergoing cardiac surgery, pediatric craniosynostosis patients, or in rheumatoid arthritis patients. The inflammatory response was not affected by administration form of TXA (oral, intravenous, or topical). In conclusion, an anti-inflammatory effect of TXA was consistently found among orthopaedic patients only.<\/jats:p>","DOI":"10.1055\/s-0042-1742741","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T22:56:46Z","timestamp":1653951406000},"page":"568-595","source":"Crossref","is-referenced-by-count":43,"title":["Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review"],"prefix":"10.1055","volume":"48","author":[{"given":"S\u00f8ren Hauge","family":"Okholm","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Health, Aarhus University, Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Krog","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Aarhus University Hospital, Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Mette","family":"Hvas","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Health, Aarhus University, Aarhus C, Denmark"},{"name":"Department of Clinical Biochemistry, Aarhus University Hospital, Aarhus C, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","author":"WOMAN Trial Collaborators","year":"2017","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"H Shakur","year":"2010","journal-title":"Lancet"},{"issue":"01","key":"ref3","first-page":"CD001886","article-title":"Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion","author":"D A Henry","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(17)32455-8","article-title":"Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40\u2008138 bleeding patients","volume":"391","author":"A Gayet-Ageron","year":"2018","journal-title":"Lancet"},{"issue":"02","key":"ref5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1055\/s-0036-1592302","article-title":"Plasmin(ogen) at the nexus of fibrinolysis, inflammation, and complement","volume":"43","author":"J H Foley","year":"2017","journal-title":"Semin Thromb Hemost"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jth.12064","article-title":"Plasminogen receptors and their role in the pathogenesis of inflammatory, autoimmune and malignant disease","volume":"11","author":"A Godier","year":"2013","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ebiom.2016.02.011","article-title":"Complement activation in arterial and venous thrombosis is mediated by plasmin","volume":"5","author":"J H Foley","year":"2016","journal-title":"EBioMedicine"},{"issue":"12","key":"ref8","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1182\/blood.V97.12.3941","article-title":"Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKKbeta-mediated NF-kappaB activation","volume":"97","author":"T Syrovets","year":"2001","journal-title":"Blood"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1161\/ATVBAHA.109.202044","article-title":"Plasmin triggers chemotaxis of monocyte-derived dendritic cells through an Akt2-dependent pathway and promotes a T-helper type-1 response","volume":"30","author":"X Li","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"04","key":"ref10","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/TA.0000000000002177","article-title":"Tranexamic acid suppresses the release of mitochondrial DAMPs and reduces lung inflammation in a murine burn model","volume":"86","author":"D W Carter","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"key":"ref11","first-page":"125","article-title":"Tranexamic acid administration modulates innate and adaptive immunity in a murine model of traumatic brain injury","volume":"53","author":"C B Bergmann","year":"2020","journal-title":"Shock"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.surg.2019.10.009","article-title":"Early intravenous administration of tranexamic acid ameliorates intestinal barrier injury induced by neutrophil extracellular traps in a rat model of trauma\/hemorrhagic shock","volume":"167","author":"C Chu","year":"2020","journal-title":"Surgery"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/TA.0000000000002092","article-title":"Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner","volume":"86","author":"C D Barrett","year":"2019","journal-title":"J Trauma Acute Care Surg"},{"issue":"04","key":"ref14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/ced.14115","article-title":"The emerging importance of tranexamic acid in dermatology","volume":"45","author":"E Forbat","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref15","first-page":"345","article-title":"The influence of tranexamic acid on skin barrier function and inflammation in rosacea","volume":"42","author":"N Sun","year":"2013","journal-title":"J Clin Dermatol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"AB4","DOI":"10.1016\/j.jaad.2016.02.014","article-title":"Combination of skin micro-needling and topical application of tranexamic acid and vitamin C: new clinical application: a pilot study for treatment of persistent post acne erythema","volume":"74","author":"H Abdelrazik","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"A Liberati","year":"2009","journal-title":"BMJ"},{"issue":"10","key":"ref19","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1182\/bloodadvances.2019000092","article-title":"Tranexamic acid modulates the immune response and reduces postsurgical infection rates","volume":"3","author":"D F Draxler","year":"2019","journal-title":"Blood Adv"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10787-020-00695-6","article-title":"Tranexamic acid attenuates inflammatory effect and modulates immune response in primary total knee arthroplasty: a randomized, placebo-controlled, pilot trial","volume":"28","author":"S Zhang","year":"2020","journal-title":"Inflammopharmacology"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.spinee.2020.10.011","article-title":"The effect of multiple-dose oral versus intravenous tranexamic acid in reducing postoperative blood loss and transfusion rate after adolescent scoliosis surgery: a randomized controlled trial","volume":"21","author":"Z Zhang","year":"2021","journal-title":"Spine J"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/jth.14316","article-title":"The antifibrinolytic and anti-inflammatory effects of multiple doses of oral tranexamic acid in total knee arthroplasty patients: a randomized controlled trial","volume":"16","author":"D Wang","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"01","key":"ref23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1055\/s-0038-1676625","article-title":"Effect of multiple doses of oral tranexamic acid on haemostasis and inflammatory reaction in total hip arthroplasty: a randomized controlled trial","volume":"119","author":"D Wang","year":"2019","journal-title":"Thromb Haemost"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijsu.2019.03.011","article-title":"The efficacy and safety of multiple doses of oral tranexamic acid on blood loss, inflammatory and fibrinolysis response following total knee arthroplasty: a randomized controlled trial","volume":"65","author":"Y Tang","year":"2019","journal-title":"Int J Surg"},{"issue":"24","key":"ref25","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.2106\/JBJS.16.01525","article-title":"Intravenous and topical tranexamic acid alone are superior to tourniquet use for primary total knee arthroplasty: a prospective, randomized controlled trial","volume":"99","author":"Z Huang","year":"2017","journal-title":"J Bone Joint Surg Am"},{"issue":"01","key":"ref26","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/aas.13700","article-title":"Effect of tranexamic acid on markers of inflammation in children undergoing craniofacial surgery","volume":"65","author":"C Fenger-Eriksen","year":"2021","journal-title":"Acta Anaesthesiol Scand"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.thromres.2018.09.054","article-title":"Efficacy and safety of multiple boluses of oral versus intravenous tranexamic acid at reducing blood loss after primary total knee arthroplasty without a tourniquet: a prospective randomized clinical trial","volume":"171","author":"G Cao","year":"2018","journal-title":"Thromb Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1749-8090-6-138","article-title":"Safety and effectiveness of two treatment regimes with tranexamic acid to minimize inflammatory response in elective cardiopulmonary bypass patients: a randomized double-blind, dose-dependent, phase IV clinical trial","volume":"6","author":"J J Jim\u00e9nez","year":"2011","journal-title":"J Cardiothorac Surg"},{"key":"ref29","first-page":"103092","article-title":"Effects of carbazochrome sodium sulfonate combined with tranexamic acid on hemostasis and inflammation during perioperative period of total hip arthroplasty: a randomized controlled trial","volume":"103092","author":"Y Luo","year":"2021","journal-title":"Orthop Traumatol Surg Res"},{"issue":"06","key":"ref30","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/cc6173","article-title":"Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis: a case control study followed by a randomized double-blind controlled trial","volume":"11","author":"J J Jimenez","year":"2007","journal-title":"Crit Care"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.thromres.2018.02.007","article-title":"The effect of oral versus intravenous tranexamic acid in reducing blood loss after primary total hip arthroplasty: a randomized clinical trial","volume":"164","author":"G Cao","year":"2018","journal-title":"Thromb Res"},{"issue":"01","key":"ref32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtcvs.2003.10.034","article-title":"Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: comparison between on-pump and off-pump techniques","volume":"128","author":"V Casati","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"03","key":"ref33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bja.2020.05.054","article-title":"High-dose versus low-dose tranexamic acid for paediatric craniosynostosis surgery: a double-blind randomised controlled non-inferiority trial","volume":"125","author":"S M Goobie","year":"2020","journal-title":"Br J Anaesth"},{"issue":"01","key":"ref34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13018-018-0855-5","article-title":"Tranexamic acid is associated with selective increase in inflammatory markers following total knee arthroplasty (TKA): a pilot study","volume":"13","author":"A L Grant","year":"2018","journal-title":"J Orthop Surg Res"},{"issue":"23","key":"ref35","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2106\/JBJS.19.00258","article-title":"Comparison of topical and intravenous tranexamic acid for total knee replacement: a randomized double-blinded controlled study of effects on tranexamic acid levels and thrombogenic and inflammatory marker levels","volume":"101","author":"K M Jules-Elysee","year":"2019","journal-title":"J Bone Joint Surg Am"},{"issue":"06","key":"ref36","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jtcvs.2012.11.042","article-title":"Antifibrinolytics attenuate inflammatory gene expression after cardiac surgery","volume":"145","author":"A FL Later","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"08","key":"ref37","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00402-020-03442-2","article-title":"Additional benefits of multiple-dose tranexamic acid to anti-fibrinolysis and anti-inflammation in total knee arthroplasty: a randomized controlled trial","volume":"140","author":"Y Lei","year":"2020","journal-title":"Arch Orthop Trauma Surg"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00264-017-3519-x","article-title":"The efficacy and safety of multiple-dose intravenous tranexamic acid on blood loss following total knee arthroplasty: a randomized controlled trial","volume":"41","author":"Y Lei","year":"2017","journal-title":"Int Orthop"},{"issue":"03","key":"ref39","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00264-019-04469-w","article-title":"The antifibrinolytic and anti-inflammatory effects of a high initial-dose tranexamic acid in total knee arthroplasty: a randomized controlled trial","volume":"44","author":"Y T Lei","year":"2020","journal-title":"Int Orthop"},{"issue":"04","key":"ref40","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/03009748409111311","article-title":"Lack of effect of tranexamic acid on rheumatoid arthritis","volume":"13","author":"G G Rasmussen","year":"1984","journal-title":"Scand J Rheumatol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"105766","DOI":"10.1016\/j.clineuro.2020.105766","article-title":"The efficacy and safety of multiple-dose intravenous tranexamic acid in reducing perioperative blood loss in patients with thoracolumbar burst fracture","volume":"193","author":"F Wang","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"ref42","first-page":"5207517","article-title":"Tranexamic acid reduces total blood loss and inflammatory response in computer-assisted navigation total knee arthroplasty","volume":"2019","author":"K T Wu","year":"2019","journal-title":"BioMed Res Int"},{"issue":"11","key":"ref43","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1302\/0301-620X.99B11.BJJ-2017-0488.R1","article-title":"Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total hip arthroplasty: a randomised clinical trial","volume":"99-B","author":"J Xie","year":"2017","journal-title":"Bone Joint J"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1016\/j.arth.2016.04.034","article-title":"multiple boluses of intravenous tranexamic acid to reduce hidden blood loss after primary total knee arthroplasty without tourniquet: a randomized clinical trial","volume":"31","author":"J Xie","year":"2016","journal-title":"J Arthroplasty"},{"issue":"01","key":"ref45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/SCS.0000000000007019","article-title":"Usefulness of tranexamic acid administration during sagittal split ramus osteotomy","volume":"32","author":"M Yoshida","year":"2021","journal-title":"J Craniofac Surg"},{"issue":"11","key":"ref46","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00264-021-05182-3","article-title":"Tranexamic acid attenuates early post-operative systemic inflammatory response and nutritional loss and avoids reduction of fibrinogen in total hip arthroplasty within an enhanced recovery after surgery pathway","volume":"45","author":"C Changjun","year":"2021","journal-title":"Int Orthop"},{"issue":"01","key":"ref47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/os.12850","article-title":"Effect of multiple doses of intravenous tranexamic acid on perioperative blood loss in total knee arthroplasty: a randomized controlled study","volume":"13","author":"B X Kang","year":"2021","journal-title":"Orthop Surg"},{"issue":"03","key":"ref48","first-page":"359","article-title":"No therapeutic effect of plasmin antagonist tranexamic acid in rheumatoid arthritis. A double-blind placebo-controlled pilot study","volume":"21","author":"W H van der Laan","year":"2003","journal-title":"Clin Exp Rheumatol"},{"issue":"01","key":"ref49","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1532\/HSF98.20121072","article-title":"Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery","volume":"16","author":"T T Chen","year":"2013","journal-title":"Heart Surg Forum"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.31925\/farmacia.2020.6.16","article-title":"Application of tranexamic acid for the perioperative period of patients undergoing scoliosis correction surgery","volume":"68","author":"W Li","year":"2020","journal-title":"Farmacia"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbi.2018.02.013","article-title":"Rethinking IL-6 and CRP: why they are more than inflammatory biomarkers, and why it matters","volume":"70","author":"M Del Giudice","year":"2018","journal-title":"Brain Behav Immun"},{"key":"ref52","first-page":"507151","article-title":"Anti-inflammatory effects of heparin and its derivatives: a systematic review","volume":"2015","author":"S Mousavi","year":"2015","journal-title":"Adv Pharmacol Sci"},{"issue":"03","key":"ref53","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3899\/jrheum.140382","article-title":"The role of innate immunity in osteoarthritis: when our first line of defense goes on the offensive","volume":"42","author":"E W Orlowsky","year":"2015","journal-title":"J Rheumatol"},{"issue":"11","key":"ref54","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1002\/art.39279","article-title":"Low-grade inflammation in symptomatic knee osteoarthritis: prognostic value of inflammatory plasma lipids and peripheral blood leukocyte biomarkers","volume":"67","author":"M Attur","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"04","key":"ref55","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/sji.12413","article-title":"Effects of ageing on the immune system: infants to elderly","volume":"83","author":"R Valiathan","year":"2016","journal-title":"Scand J Immunol"},{"issue":"01","key":"ref56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00540-018-2579-4","article-title":"Roles of inflammation, neurogenic inflammation, and neuroinflammation in pain","volume":"33","author":"M Matsuda","year":"2019","journal-title":"J Anesth"},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"E736","DOI":"10.3390\/medicina55110736","article-title":"Steroids and L-Lysine aescinate for acute radiculopathy due to a herniated lumbar disk","volume":"55","author":"M Oros","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"ref58","first-page":"S0020","article-title":"Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials","author":"P Masouros","year":"2021","journal-title":"Injury"}],"container-title":["Seminars in Thrombosis and Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0042-1742741.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T23:45:37Z","timestamp":1658879137000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0042-1742741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":57,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2022,7,26]]},"published-print":{"date-parts":[[2022,7]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0042-1742741","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0094-6176","1098-9064"],"issn-type":[{"value":"0094-6176","type":"print"},{"value":"1098-9064","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]}}}